DataMEDS AI, Inc.
MEDS
$0.99
$0.032.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 14.13% | -6.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.13% | -6.64% | |||
| Cost of Revenue | 15.00% | -85.42% | |||
| Gross Profit | 7.05% | 102.17% | |||
| SG&A Expenses | 23.02% | 40.82% | |||
| Depreciation & Amortization | -0.06% | -55.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.46% | -47.64% | |||
| Operating Income | -22.10% | 53.00% | |||
| Income Before Tax | -137.17% | 72.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -137.17% | 72.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -137.17% | 72.20% | |||
| EBIT | -22.10% | 53.00% | |||
| EBITDA | -23.50% | 52.83% | |||
| EPS Basic | -92.75% | 74.34% | |||
| Normalized Basic EPS | 6.81% | 46.03% | |||
| EPS Diluted | -92.75% | 74.34% | |||
| Normalized Diluted EPS | 6.81% | 46.03% | |||
| Average Basic Shares Outstanding | 23.05% | 8.34% | |||
| Average Diluted Shares Outstanding | 23.05% | 8.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||